The emerging therapy of the medication represents a significant advance in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide443372.iyublog.com/40738019/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment